|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.03 USD | +1.62% |
|
+1.41% | +6.79% |
| Apr. 23 | Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering | MT |
| Apr. 23 | SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa | CI |
SOPHiA GENETICS is provided earnings guidance for 2024. For the period, company expects Revenue between $78 million and $81 million, representing growth of 25% to 30% compared to full year 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| +6.79% | 328M | |
| +8.05% | 3,020B | |
| +5.58% | 82.93B | |
| +3.69% | 76.85B | |
| -14.62% | 53.04B | |
| +31.16% | 50.15B | |
| -24.56% | 46.71B | |
| +17.75% | 41.41B | |
| +55.21% | 36.1B | |
| -10.24% | 24.64B |
SOPHIA GENETICS SA 
